Key Points:
·Ispire Malaysia's subsidiary has announced that its production activities are intended exclusively for export.
·The company's products do not contain nicotine or marijuana ingredients, and are not sold in the Malaysian market.
·Its technology is only meant for adult use and within compliant regions.
Ispire Malaysia Sdn Bhd, a subsidiary of Ispire, reiterated on June 9th its strict compliance with all applicable laws and regulations in Malaysia.
Ispire Malaysia has confirmed that all production activities at its factory in Johor are solely for export and do not involve manufacturing or distributing any e-liquid or gel products containing nicotine or marijuana in Malaysia.
In a statement, Inspire's Co-CEO Michael Wang said:
"Ispire Malaysia operates under strict protocols to ensure that 100% of its production is for export. We believe our operations are fully compliant with Malaysian laws, and we are committed to maintaining transparency and cooperation at both federal and state levels."
Key clarifications include:
·Not distributed locally: All products manufactured in Malaysia are not sold, distributed, or marketed in the local market.
·No nicotine or marijuana ingredients: The factory only produces semi-finished vaporizer hardware, and the production process does not involve e-liquids or gel products.
·Not manufacturing medical devices: While the factory is capable of producing certified components, it has not currently produced any medical devices. Any future activities in this field will require comprehensive regulatory review.
·Advanced safety features: Ispire products will integrate age restrictions and geofencing technology based on blockchain, ensuring that only adults and compliant regions can use them. The company's patented technology has been submitted for review by the U.S. Food and Drug Administration (FDA).
The company pointed out that recent rumors about cannabis products pertain to its legal product marketing materials in the United States, and do not reflect the nature of its operations in Malaysia.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
